首页> 外国专利> Targeted drug delivery system for cancer diagnosis or treatment containing liposome labeled with peptide specifically targeting interleukin-4 receptor and method for producing the same

Targeted drug delivery system for cancer diagnosis or treatment containing liposome labeled with peptide specifically targeting interleukin-4 receptor and method for producing the same

机译:用于癌症诊断或治疗的靶向药物递送系统,其包含用特异性靶向白介素4受体的肽标记的脂质体及其制备方法

摘要

The present invention relates to a target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and a manufacturing method thereof. The liposome which contains anticancer drugs labeled with IL4RPep peptides prepared in accordance with the present invention can deliver drugs to cancer cells in which IL-4 receptors are overexpressed by IL4RPep peptides which specifically bind to IL-4 receptors, and the drug delivery can recognize cancer cells specifically by a label. Thus, IL4RPep peptides can increase the effect of drugs only on cancer tissues and at the same time significantly reduce the side effects on normal tissues, which makes possible in vivo(molecular) imaging and early diagnosis of tumors. Therefore, the liposome which contains anticancer drugs labeled with IL4Pep peptides of the present invention can be applied, as the target-aiming drug delivery system, effectively to the diagnosis and treatment of cancers.
机译:本发明涉及一种用于诊断和治疗含有被特异性标记白介素4受体的肽标记的脂质体的癌症的靶向药物递送系统及其制造方法。包含根据本发明制备的用IL4RPep肽标记的抗癌药物的脂质体可以将药物递送至其中IL-4受体被特异性结合IL-4受体的IL4RPep肽过表​​达的癌细胞,并且该药物递送可以识别癌症单元格专门通过标签。因此,IL4RPep肽只能增加药物对癌组织的作用,同时显着降低对正常组织的副作用,这使得体内(分子)成像和肿瘤的早期诊断成为可能。因此,含有被本发明的IL4Pep肽标记的抗癌药的脂质体可以作为靶标给药系统有效地用于癌症的诊断和治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号